277 related articles for article (PubMed ID: 21744999)
1. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
2. Fibulin-5 is Down-Regulated in Colorectal Cancer and Correlated with Clinicopathologic Characteristics.
Chen Z; Wang Z; Chen J; Li Z
Clin Lab; 2018 Jan; 64(1):25-31. PubMed ID: 29479873
[TBL] [Abstract][Full Text] [Related]
3. CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer.
Wang Z; Yuan X; Jiao N; Zhu H; Zhang Y; Tong J
Pathol Oncol Res; 2012 Apr; 18(2):263-70. PubMed ID: 21796503
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.
Xu Z; Chen H; Liu D; Huo J
Medicine (Baltimore); 2015 Apr; 94(13):e663. PubMed ID: 25837757
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
7. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
8. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
9. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
10. Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation.
Smith E; Tomita Y; Palethorpe HM; Howell S; Nakhjavani M; Townsend AR; Price TJ; Young JP; Hardingham JE
Epigenetics; 2019 Feb; 14(2):158-170. PubMed ID: 30739527
[TBL] [Abstract][Full Text] [Related]
11. EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer.
Wang Y; Xuan Z; Wang B; Zhang D; Zhang C; Wang J; Sun Y
Dig Dis Sci; 2019 Jun; 64(6):1514-1522. PubMed ID: 30560328
[TBL] [Abstract][Full Text] [Related]
12. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
13. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
[TBL] [Abstract][Full Text] [Related]
15. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
[TBL] [Abstract][Full Text] [Related]
16. Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.
Semaan A; Uhl B; Branchi V; Lingohr P; Bootz F; Kristiansen G; Kalff JC; Matthaei H; Pantelis D; Dietrich D
Clin Colorectal Cancer; 2018 Jun; 17(2):e385-e393. PubMed ID: 29580650
[TBL] [Abstract][Full Text] [Related]
17. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
Tae CH; Ryu KJ; Kim SH; Kim HC; Chun HK; Min BH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
BMC Cancer; 2013 Mar; 13():142. PubMed ID: 23517143
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
Kumar A; Gosipatala SB; Pandey A; Singh P
Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
[TBL] [Abstract][Full Text] [Related]
19. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
[TBL] [Abstract][Full Text] [Related]
20. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]